Refractory metastatic Crohn’s disease responsive to ustekinumab dose intensification

Detalles Bibliográficos
Autores principales: Xiao, Teresa L., Ezenwa, Ekene, Ruiz de Luzuriaga, Arlene, Hoffman, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841365/
https://www.ncbi.nlm.nih.gov/pubmed/36654767
http://dx.doi.org/10.1016/j.jdcr.2022.11.028
_version_ 1784869825005223936
author Xiao, Teresa L.
Ezenwa, Ekene
Ruiz de Luzuriaga, Arlene
Hoffman, Mark D.
author_facet Xiao, Teresa L.
Ezenwa, Ekene
Ruiz de Luzuriaga, Arlene
Hoffman, Mark D.
author_sort Xiao, Teresa L.
collection PubMed
description
format Online
Article
Text
id pubmed-9841365
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98413652023-01-17 Refractory metastatic Crohn’s disease responsive to ustekinumab dose intensification Xiao, Teresa L. Ezenwa, Ekene Ruiz de Luzuriaga, Arlene Hoffman, Mark D. JAAD Case Rep Case Report Elsevier 2022-12-05 /pmc/articles/PMC9841365/ /pubmed/36654767 http://dx.doi.org/10.1016/j.jdcr.2022.11.028 Text en © 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access.. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Xiao, Teresa L.
Ezenwa, Ekene
Ruiz de Luzuriaga, Arlene
Hoffman, Mark D.
Refractory metastatic Crohn’s disease responsive to ustekinumab dose intensification
title Refractory metastatic Crohn’s disease responsive to ustekinumab dose intensification
title_full Refractory metastatic Crohn’s disease responsive to ustekinumab dose intensification
title_fullStr Refractory metastatic Crohn’s disease responsive to ustekinumab dose intensification
title_full_unstemmed Refractory metastatic Crohn’s disease responsive to ustekinumab dose intensification
title_short Refractory metastatic Crohn’s disease responsive to ustekinumab dose intensification
title_sort refractory metastatic crohn’s disease responsive to ustekinumab dose intensification
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841365/
https://www.ncbi.nlm.nih.gov/pubmed/36654767
http://dx.doi.org/10.1016/j.jdcr.2022.11.028
work_keys_str_mv AT xiaoteresal refractorymetastaticcrohnsdiseaseresponsivetoustekinumabdoseintensification
AT ezenwaekene refractorymetastaticcrohnsdiseaseresponsivetoustekinumabdoseintensification
AT ruizdeluzuriagaarlene refractorymetastaticcrohnsdiseaseresponsivetoustekinumabdoseintensification
AT hoffmanmarkd refractorymetastaticcrohnsdiseaseresponsivetoustekinumabdoseintensification

Ejemplares similares